Data from Greater Bay Area residents to help improve healthcare policy: GSK Executive says pharmaceutical company is investing in shared data infrastructure.

News summary

British pharmaceutical company GSK is turning to patient data gathered from the 88 million residents of the Greater Bay Area’s 11 cities to speed up drug development in vaccines and cancer care, as officials push for closer cross-border medical cooperation.